LGVN Stock Alert: Longeveron Pops 18% on FDA Fast-Track Designation

This has the Food and Drug Administration (FDA) granting this designation to Lomecel-B. This will help assist with the speedy development and review of the treatment. That allows for the drug to make it to market sooner than it would without fast-track status. With this fast-track designation news comes heavy trading of LGVN stock on Wednesday. That has more than 23 million shares on the move as of this writing. This is well above its daily average trading volume of about 9.6 million shares. On Penny Stocks ...